PHOREMOST

• 72110 - Research and experimental development on biotechnology

Through its SITESEEKER® drug target identification platform, PhoreMost is expanding druggable space. In partnership, we are discovering and developing the ... PhoreMost makes key appointments to Board to advance development of next-generation degrader therapeutics... PhoreMost has developed a next-generation phenotypic screening platform called SITESEEKER® which can discern the best new targets for future therapies and, crucially

Also known as: PHOREMOST LIMITED, PhoreMost Ltd.

Registration numbers: 08969798 (CH), ZA399167 (W)

Primary location: Cambridge United Kingdom